Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational profiling in patients with MDS: ready for every-day use in the clinic?

Best practice & research. Clinical haematology - 1 Mar 2015

Bacher Ulrike, Kohlmann Alexander, Haferlach Torsten

Abstract excerpt

Multiple recurrent somatic mutations were identified in the majority of patients with myelodysplastic syndromes (MDS), but investigating the broad spectrum of molecular markers in MDS exceeds many laboratories' capacity when traditional molecular techniques are used. High-throughput second genera...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Leukemia, Myeloid, Acute
Share to Myelodysplastic Syndromes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Sensitivity and Specificity

Share to Stem Cell Transplantation

Share to Survival Analysis

Share to Transplantation, Homologous

Source

Identifiers

PMID: 25659728
DOI: 10.1016/j.beha.2014.11.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25659728-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational profiling in patients with MDS: ready for every-day use in the clinic?PMID 25659728Read ↗

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Semantic proximity Read ↗

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencingSemantic proximity Read ↗

Monitoring molecular changes in the management of myelodysplastic syndromes.Semantic proximity Read ↗

Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.Semantic proximity Read ↗

Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?Semantic proximity Read ↗

Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.Semantic proximity Read ↗

Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.Semantic proximity Read ↗

Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.Semantic proximity Read ↗

Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes.Semantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Next‐generation sequencing – feasibility and practicality in haematologySemantic proximity Read ↗

Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.